Stomach, Nasopharyngeal, and Prostate Cancers, 01/18/2024

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Removing Stomach to Prevent Cancer Can Cause Lasting Problems   In a recent study, more than 90% of people who had their stomach removed to prevent cancer have at least one chronic problem 2 years after their surgery. For some, the problems are life altering. Read More First Immunotherapy Drug Approved for Nasopharyngeal Cancer   The Food and Drug Administration (FDA) approved toripalimab (Loqtorzi) for nasopharyngeal cancer that has come back or spread after treatment. The results from a large clinical trial showed that, when added to chemotherapy, the drug increased how long people with this cancer lived. Read More Hormone Therapy Gets Added Approval for Prostate Cancer That Hasn't Spread   Under a new FDA approval, enzalutamide (Xtandi) can now be used alone, or with leuprolide, to treat some people with prostate cancer. This approval adds to the number of treatment options for prostate cancer that has greatly increased over the last decade. Read More Spirituality and Cancer Care Religion and spirituality in cancer care are very personal matters that can affect your treatment decisions and the ability to cope. Learn how your health care team can support your spiritual and religious well-being and how this can lead to improved health and quality of life. Read More   Contact Us   Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892